Semaglutide was FDA-approved for chronic weight management in 2021 (as Wegovy), and tirzepatide just received FDA approval for weight loss in late 2023 under the brand name Zepbound (it was previously approved for type 2 diabetes as Mounjaro)
If this sounds like your situation, you should know youre not the only one
Patients treated for differentiated thyroid cancer are monitored carefully with physical examinations, serum quantitative thyroglobulin levels, and radiological studies based on individual risk for recurrent disease.[32] Treatment options for recurrent papillary and follicular thyroid cancer Treatment options for recurrent papillary and follicular thyroid cancer include: Surgery with or without postoperative RAI therapy Surgery with or without 131I ablation can be useful in controlling local recurrences, regional node metastases, or occasionally, metastases at other localized sites.[33] Approximately 50% of the patients who undergo surgery for recurrent tumors can be rendered free of disease with a second operation.[30] Local and regional recurrences detected by 131I scan and not clinically apparent can be treated with 131I ablation and have an excellent prognosis.[34] Up to 25% of recurrences and metastases from well-differentiated thyroid cancer may not show 131I uptake
For lasting weight loss results, it is recommended to adopt a holistic approach that includes both medication and lifestyle changes
Who Should Choose Each Platform Choose Hims If: You are a man who specifically wants FDA-approved Wegovy or Zepbound rather than compounded medication You have insurance that covers Hims brand-name drugs and want to use it You want a mens health platform that covers multiple conditions beyond weight loss You are concerned about the regulatory future of compounded GLP-1s and prefer the brand-name pathway Choose Mochi Health If: You want the lowest ongoing monthly cost Mochi Health is approximately 40% cheaper than Hims for semaglutide You are comfortable with compounded medication from a licensed U.S
No evidence-based dosing, delivery method, or safety profile is available
